摘要
背景:量子化学方法和分子力学方法在药物代谢研究中面临着许多挑战,因为它们要么是精确度不够,要么是计算量大,要么是缺乏c。用于建立计算模型的李尔分子水平图。低成本的qsr方法通常可以实现,尽管分子水平的图像没有很好的定义,但是它们显示出困难。确定药物代谢机制和描述化学结构对药物毒性的影响,因为一定数量的分子描述符难以解释。. 目的:利用机械解释的分子描述符与生物活性相关联,建立结构-活性图,以实现QSAR的突破。比奥洛化学活性是蒽环类抗肿瘤抗生素的致死性,被称为log LD 50。机械解释的分子描述符包括亲电性和数学功能。伦敦色散相互作用公式中的离子。 方法:用量子化学方法计算描述子。 结果:电亲性图被解释为蒽环类化合物的氧化还原活性,可以描述氧化降解解毒和还原生物活化对毒性的影响。艾尔。分散相互作用函数图代表了蒽环类化合物和生物分子之间的吸引力,可以描述从毒性靶细胞流出和流入目标细胞的情况。。这些地块还可以识别三种具有不同代谢途径的蒽环类化合物的结构支架,从而导致它们的毒性行为不同。 结论:本研究揭示的结构依赖性毒性行为可为药物设计和药物代谢研究提供理论依据。
关键词: 蒽环类,嗜电性,分散相互作用,药物毒性,定量结构-活性关系,量子化学方法。
Current Cancer Drug Targets
Title:Redox Biotransformation and Delivery of Anthracycline Anticancer Antibiotics: How Interpretable Structure-activity Relationships of Lethality Using Electrophilicity and the London Formula for Dispersion Interaction Work
Volume: 18 Issue: 6
关键词: 蒽环类,嗜电性,分散相互作用,药物毒性,定量结构-活性关系,量子化学方法。
摘要: Background: Quantum chemical methods and molecular mechanics approaches face a lot of challenges in drug metabolism study because of either insufficient accuracy, huge computational cost, or lack of clear molecular level pictures for building computational models. Low-cost QSAR methods can often be carried out, even though molecular level pictures are not well defined; however, they show difficulty in identifying the mechanisms of drug metabolism and delineating the effects of chemical structures on drug toxicity because a certain amount of molecular descriptors are difficult to be interpreted.
Objective: In order to make a breakthrough of QSAR, mechanistically interpretable molecular descriptors were used to correlate with biological activity to establish structure-activity plots. The biological activity is the lethality of anthracycline anticancer antibiotics denoted as log LD50. The mechanistically interpretable molecular descriptors include electrophilicity and the mathematical function in the London formula for dispersion interaction.
Method: The descriptors were calculated using quantum chemical methods.
Results: The plots for electrophilicity, which is interpreted as redox reactivity of anthracyclines, can describe oxidative degradation for detoxification and reductive bioactivation for toxicity induction. The plots for the dispersion interaction function, which represents the attraction between anthracyclines and biomolecules, can describe efflux from and influx into the target cells of toxicity. The plots can also identify three structural scaffolds of anthracyclines that have different metabolic pathways, resulting in their different toxicity behavior.
Conclusion: This structure-dependent toxicity behavior revealed in the plots can provide perspectives on drug design and drug metabolism study.
Export Options
About this article
Cite this article as:
Redox Biotransformation and Delivery of Anthracycline Anticancer Antibiotics: How Interpretable Structure-activity Relationships of Lethality Using Electrophilicity and the London Formula for Dispersion Interaction Work, Current Cancer Drug Targets 2018; 18 (6) . https://dx.doi.org/10.2174/1568009617666170330145709
DOI https://dx.doi.org/10.2174/1568009617666170330145709 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Indirect Production of No Carrier Added (NCA) <sup>177</sup>Lu from Irradiation of Enriched <sup>176</sup>Yb: Options for Ytterbium/Lutetium Separation
Current Radiopharmaceuticals Transition Metal Based Anticancer Drugs
Current Topics in Medicinal Chemistry Targeting the Resistance of Pancreatic Cancer Cells to Nutrient Deprivation: Anti-Austerity Compounds
Current Drug Delivery Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Nutritional Interventions for Elderly and Considerations for the Development of Geriatric Foods
Current Aging Science Monoclonal Antibodies Against Epidermal Growth Factor Receptor in Advanced Colorectal Carcinoma: Clinical Efficacy and Markers of Sensitivity&#
Reviews on Recent Clinical Trials Passive Smoking and Coronary Heart Disease
Current Vascular Pharmacology The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives
Current Clinical Pharmacology Therapeutic Polycomb Targeting in Human Cancer
Recent Patents on Regenerative Medicine GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews Alpha Fetoprotein is More than a Hepatocellular Cancer Biomarker: From Spontaneous Immune Response in Cancer Patients to the Development of an AFP-Based Cancer Vaccine
Current Molecular Medicine Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeted Nanosystems for Cancer Therapy
Current Cancer Therapy Reviews Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Transcriptional Regulation of mPGES1 in Cancer: An Alternative Approach to Drug Discovery?
Current Drug Targets Microarrays and Mass Spectrometry - The Future of Proteomics
Current Genomics Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Application of Supercritical Fluid in Nanolithographic Processes
Recent Patents on Nanotechnology Hypertension and Angiogenesis
Current Pharmaceutical Design